tacrolimus

Tacrolimus is a lipid of Polyketides (PK) class. Tacrolimus is associated with abnormalities such as Renal glomerular disease. The involved functions are known as inhibitors, Fungicidal activity, Metabolic Inhibition, Excretory function and Dephosphorylation. Tacrolimus often locates in Hepatic, Mitochondrial matrix and Inner mitochondrial membrane. The associated genes with Tacrolimus are RHOA gene and BGN gene.

Cross Reference

Introduction

To understand associated biological information of tacrolimus, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with tacrolimus?

tacrolimus is suspected in Renal glomerular disease, Candidiasis, Mycoses, PARKINSON DISEASE, LATE-ONSET, Morphologically altered structure, Skin Diseases, Infectious and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with tacrolimus

MeSH term MeSH ID Detail
Gastrointestinal Diseases D005767 20 associated lipids
Genital Diseases, Female D005831 7 associated lipids
Castleman Disease D005871 3 associated lipids
Gingival Hyperplasia D005885 3 associated lipids
Gingivitis D005891 3 associated lipids
Glioma D005910 112 associated lipids
Gliosis D005911 6 associated lipids
Glomerulonephritis D005921 35 associated lipids
Glomerulosclerosis, Focal Segmental D005923 4 associated lipids
Glycosuria D006029 10 associated lipids
Gout D006073 4 associated lipids
Graft Occlusion, Vascular D006083 11 associated lipids
Granuloma, Giant Cell D006101 7 associated lipids
Graves Disease D006111 6 associated lipids
Gynecomastia D006177 6 associated lipids
Hallucinations D006212 4 associated lipids
Hand Dermatoses D006229 5 associated lipids
Hand Injuries D006230 1 associated lipids
Headache D006261 4 associated lipids
Hearing Loss, Bilateral D006312 1 associated lipids
Hearing Loss, Noise-Induced D006317 4 associated lipids
Heart Defects, Congenital D006330 20 associated lipids
Cardiomegaly D006332 31 associated lipids
Heart Failure D006333 36 associated lipids
Heart Injuries D006335 6 associated lipids
Hematologic Diseases D006402 3 associated lipids
Hematoma D006406 5 associated lipids
Hematuria D006417 13 associated lipids
Hemolysis D006461 131 associated lipids
Hemolytic-Uremic Syndrome D006463 2 associated lipids
Hemophilia A D006467 10 associated lipids
Hemorrhage D006470 15 associated lipids
Budd-Chiari Syndrome D006502 1 associated lipids
Hepatic Veno-Occlusive Disease D006504 1 associated lipids
Hepatitis, Viral, Animal D006524 4 associated lipids
Hepatitis C D006526 7 associated lipids
Hepatolenticular Degeneration D006527 3 associated lipids
Carcinoma, Hepatocellular D006528 140 associated lipids
Hernia, Ventral D006555 1 associated lipids
Herpes Labialis D006560 1 associated lipids
Herpesviridae Infections D006566 4 associated lipids
HIV Seropositivity D006679 15 associated lipids
Deltaretrovirus Infections D006800 1 associated lipids
Hydronephrosis D006869 4 associated lipids
Hyperalgesia D006930 42 associated lipids
Hyperbilirubinemia D006932 11 associated lipids
Hypercalcemia D006934 13 associated lipids
Hypercholesterolemia D006937 91 associated lipids
Hyperglycemia D006943 21 associated lipids
Hyperkalemia D006947 3 associated lipids
Per page 10 20 50 100 | Total 613

PubChem Associated disorders and diseases

What pathways are associated with tacrolimus

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with tacrolimus?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with tacrolimus?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with tacrolimus?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with tacrolimus?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with tacrolimus?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with tacrolimus

Download all related citations
Per page 10 20 50 100 | Total 15051
Authors Title Published Journal PubMed Link
Gokhale NS Systematic approach to managing vernal keratoconjunctivitis in clinical practice: Severity grading system and a treatment algorithm. 2016 Indian J Ophthalmol pmid:27050351
Rotenstein L et al. Management of refractory autoimmune hemolytic anemia via allogeneic stem cell transplantation. 2016 Bone Marrow Transplant. pmid:27272445
Wen Y et al. Tacrolimus restores podocyte injury and stabilizes the expression of Cabin1 in 5/6 nephrectomized rats. 2016 Ren Fail pmid:26905810
Törlén J et al. A prospective randomized trial comparing cyclosporine/methotrexate and tacrolimus/sirolimus as graft-versus-host disease prophylaxis after allogeneic hematopoietic stem cell transplantation. 2016 Haematologica pmid:27662016
Martial LC et al. A preliminary study searching for the right dose of tacrolimus in very young (≤4 years) renal transplant patients. 2016 J. Pharm. Pharmacol. pmid:27669677
Chang KT et al. Tacrolimus suppresses atopic dermatitis-associated cytokines and chemokines in monocytes. 2016 J Microbiol Immunol Infect pmid:25315214
Zeng W et al. Hyaluronic acid-coated niosomes facilitate tacrolimus ocular delivery: Mucoadhesion, precorneal retention, aqueous humor pharmacokinetics, and transcorneal permeability. 2016 Colloids Surf B Biointerfaces pmid:26820107
Nuki Y et al. Comparison of the therapeutic efficacy and safety between tacrolimus and infliximab for moderate-to-severe ulcerative colitis: a single center experience. 2016 Scand. J. Gastroenterol. pmid:26818468
Joko T et al. Therapeutic Effect of 0.1% Topical Tacrolimus for Childhood Interstitial Keratitis Refractory to Cyclosporine. 2016 J Nippon Med Sch pmid:26960587
Malachowski SJ et al. Annular Lichenoid Dermatitis of Youth: A Chronic Case Managed Using Pimecrolimus. 2016 Pediatr Dermatol pmid:27653808
Sawada T et al. Experimental Studies on Protective Effects of FK506 Against Hepatic Ischemia-Reperfusion Injury. 2016 J. Med. Invest. pmid:27644569
Cameron AM et al. Chimeric Allografts Induced by Short-Term Treatment With Stem Cell Mobilizing Agents Result in Long-Term Kidney Transplant Survival Without Immunosuppression: II, Study in Miniature Swine. 2016 Am. J. Transplant. pmid:26748958
Chen CA et al. Quantitative analysis of tissue inflammation and responses to treatment in immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome, and review of literature. 2016 J Microbiol Immunol Infect pmid:26748735
Karagüzel G et al. Vitamin D status and the effects of oral vitamin D treatment in children with vitiligo: A prospective study. 2016 Clin Nutr ESPEN pmid:28531780
Yoshida T et al. Oral tacrolimus oil formulations for enhanced lymphatic delivery and efficient inhibition of T-cell's interleukin-2 production. 2016 Eur J Pharm Biopharm pmid:26748381
Radziejewski K and Balicki I Comparative clinical evaluation of tacrolimus and cyclosporine eye drops for the treatment of canine keratoconjunctivitis sicca. 2016 Acta Vet. Hung. pmid:27653428
Kannegieter NM et al. Conversion to Once-Daily Tacrolimus Results in Increased p38MAPK Phosphorylation in T Lymphocytes of Kidney Transplant Recipients. 2016 Ther Drug Monit pmid:26606072
Wang Z et al. Nanocomposite microparticles (nCmP) for the delivery of tacrolimus in the treatment of pulmonary arterial hypertension. 2016 Int J Pharm pmid:27568494
Rahnama-Moghadam S et al. Vesicular eruption in a 2-year-old boy. 2016 J Fam Pract pmid:27565104
Lee C et al. Treatment of bleomycin-induced pulmonary fibrosis by inhaled tacrolimus-loaded chitosan-coated poly(lactic-co-glycolic acid) nanoparticles. 2016 Biomed. Pharmacother. pmid:26898446
Zegarska J et al. Tacrolimus Metabolite M-III May Have Nephrotoxic and Myelotoxic Effects and Increase the Incidence of Infections in Kidney Transplant Recipients. 2016 Transplant. Proc. pmid:27496443
Bargnoux AS et al. Evaluation of the New Siemens Tacrolimus Assay on the Dimension EXL Integrated Chemistry System Analyzer: Comparison With an Ultra-Performance Liquid Chromatography-Tandem Mass Spectrometry Method. 2016 Ther Drug Monit pmid:27494947
Zmonarski SC et al. Lowering of Messenger Ribonucleic Acid Toll-Like Receptors 2-4,9 in Peripheral Blood Mononuclear Cells in Kidney Allograft Recipients, Relationships With Immunosuppressive Treatment, and Delayed Graft Function Occurrence. 2016 Transplant. Proc. pmid:27496439
Ashizuka S et al. Adrenomedullin Therapy in Patients with Refractory Ulcerative Colitis: A Case Series. 2016 Dig. Dis. Sci. pmid:26470867
Matsui K et al. Betamethasone, but Not Tacrolimus, Suppresses the Development of Th2 Cells Mediated by Langerhans Cell-Like Dendritic Cells. 2016 Biol. Pharm. Bull. pmid:27374298
Kimsa M et al. Transforming growth factor β-related genes in human retinal pigment epithelial cells after tacrolimus treatment. 2016 Pharmacol Rep pmid:27372923
García-Delgado R et al. Systemic Absorption of Topical Tacrolimus in Metastatic Crohn Disease With Skin Ulcers. 2016 Actas Dermosifiliogr pmid:27372545
Vignali D et al. IL-7 Mediated Homeostatic Expansion of Human CD4+CD25+FOXP3+ Regulatory T Cells After Depletion With Anti-CD25 Monoclonal Antibody. 2016 Transplantation pmid:27306531
Saitman A et al. Evaluation of the Waters MassTrak LC-MS/MS Assay for Tacrolimus and a Comparison to the Abbott Architect Immunoassay. 2016 Ther Drug Monit pmid:26473523
Tanzi MG et al. Pharmacokinetics of prolonged-release tacrolimus and implications for use in solid organ transplant recipients. 2016 Clin Transplant pmid:27220013
Yamashita T et al. Effects of CYP3A5 polymorphism on the pharmacokinetics of a once-daily modified-release tacrolimus formulation and acute kidney injury in hematopoietic stem cell transplantation. 2016 Cancer Chemother. Pharmacol. pmid:27217047
Tremblay S et al. Absence of the Effect of Pretransplant Body Mass Index on Post Kidney Transplant Outcomes. 2016 Prog Transplant pmid:27207408
Emoto C et al. Risk Assessment of Drug-Drug Interactions of Calcineurin Inhibitors Affecting Sirolimus Pharmacokinetics in Renal Transplant Patients. 2016 Ther Drug Monit pmid:27310200
Badri PS et al. Pharmacokinetics of Tacrolimus and Cyclosporine in Liver Transplant Recipients Receiving 3 Direct-Acting Antivirals as Treatment for Hepatitis C Infection. 2016 Ther Drug Monit pmid:27310199
Stifft F et al. Effect of Breakfast on the Exposure of the Once-Daily Tacrolimus Formulation in Stable Kidney Transplant Recipients. 2016 Ther Drug Monit pmid:27128604
Pirmez R et al. Acne keloidalis nuchae in renal transplant patients receiving tacrolimus and sirolimus. 2016 Australas. J. Dermatol. pmid:27124649
Khaled SK et al. Influence of Absorption, Distribution, Metabolism, and Excretion Genomic Variants on Tacrolimus/Sirolimus Blood Levels and Graft-versus-Host Disease after Allogeneic Hematopoietic Cell Transplantation. 2016 Biol. Blood Marrow Transplant. pmid:26325438
Lee DR et al. Enhanced dissolution and oral absorption of tacrolimus by supersaturable self-emulsifying drug delivery system. 2016 Int J Nanomedicine pmid:27051286
Cai SC et al. Topical calcineurin inhibitors in eczema and cancer association: A cohort study. 2016 J Dermatolog Treat pmid:27049893
Lee YH and Song GG Relative efficacy and safety of tacrolimus, mycophenolate mofetil, and cyclophosphamide as induction therapy for lupus nephritis: a Bayesian network meta-analysis of randomized controlled trials. 2015 Lupus pmid:26162684
Liao R et al. Tacrolimus Protects Podocytes from Injury in Lupus Nephritis Partly by Stabilizing the Cytoskeleton and Inhibiting Podocyte Apoptosis. 2015 PLoS ONE pmid:26161538
Kojima R et al. Release mechanisms of tacrolimus-loaded PLGA and PLA microspheres and immunosuppressive effects of the microspheres in a rat heart transplantation model. 2015 Int J Pharm pmid:26160668
Kanchongkittiphon W et al. Child with atopic dermatitis. 2015 Ann. Allergy Asthma Immunol. pmid:25528736
Velickovic-Radovanovic R et al. Gender-dependent predictable pharmacokinetic method for tacrolimus exposure monitoring in kidney transplant patients. 2015 Eur J Drug Metab Pharmacokinet pmid:24596067
Traitanon O et al. Differential Effects of Tacrolimus versus Sirolimus on the Proliferation, Activation and Differentiation of Human B Cells. 2015 PLoS ONE pmid:26087255
Seo YG et al. Solid self-nanoemulsifying drug delivery system (SNEDDS) for enhanced oral bioavailability of poorly water-soluble tacrolimus: physicochemical characterisation and pharmacokinetics. 2015 J Microencapsul pmid:26079598
Menotta M et al. Label-free quantification of Tacrolimus in biological samples by atomic force microscopy. 2015 Anal. Chim. Acta pmid:26073814
Hu WX et al. Glucocorticoid with or without additional immunosuppressant therapy for patients with lupus podocytopathy: a retrospective single-center study. 2015 Lupus pmid:25819933
Mabuchi M et al. Improvement of solid material for affinity resins by application of long PEG spacers to capture the whole target complex of FK506. 2015 Bioorg. Med. Chem. Lett. pmid:26025877
Zhang D et al. Multifunctional Poly(methyl vinyl ether-co-maleic anhydride)-graft-hydroxypropyl-β-cyclodextrin Amphiphilic Copolymer as an Oral High-Performance Delivery Carrier of Tacrolimus. 2015 Mol. Pharm. pmid:26024817
Considine A et al. Performance of modified-release tacrolimus after conversion in liver transplant patients indicates potentially favorable outcomes in selected cohorts. 2015 Liver Transpl. pmid:25312292
Taber DJ et al. African-American race modifies the influence of tacrolimus concentrations on acute rejection and toxicity in kidney transplant recipients. 2015 Pharmacotherapy pmid:26011276
Grammatikopoulos T et al. Anti-CD20 Monoclonal Antibody Therapy in Functional Bile Salt Export Pump Deficiency After Liver Transplantation. 2015 J. Pediatr. Gastroenterol. Nutr. pmid:24231640
Leyking S et al. Calcineurin inhibitors differentially alter the circadian rhythm of T-cell functionality in transplant recipients. 2015 J Transl Med pmid:25885792
Wang X et al. Tacrolimus 0.03% ointment in labial discoid lupus erythematosus: A randomized, controlled clinical trial. 2015 J Clin Pharmacol pmid:25951426
Ozbek OY and Ozcay F Long-term outcome of food allergy after liver transplantation in children. 2015 Pediatr Transplant pmid:25882294
Mistry NP et al. Formulation and evaluation of tacrolimus-loaded galactosylated Poly(lactic-co-glycolic acid) nanoparticles for liver targeting. 2015 J. Pharm. Pharmacol. pmid:25944126
Banhara PB et al. Tubular dysfunction in renal transplant patients using sirolimus or tacrolimus. 2015 Clin. Nephrol. pmid:25943142
Zhou X et al. Effect of immunosuppression on the human mesangial cell cycle. 2015 Mol Med Rep pmid:25370945
Peccerillo F et al. Eosinophilic cellulitis. 2015 G Ital Dermatol Venereol pmid:25946678
Størset E et al. Improved Tacrolimus Target Concentration Achievement Using Computerized Dosing in Renal Transplant Recipients--A Prospective, Randomized Study. 2015 Transplantation pmid:25886918
Montero N and Pascual J Immunosuppression and Post-transplant Hyperglycemia. 2015 Curr Diabetes Rev pmid:25824238
Seo YG et al. Preparation and pharmaceutical evaluation of new tacrolimus-loaded solid self-emulsifying drug delivery system. 2015 Arch. Pharm. Res. pmid:25134927
Ott M et al. Suppression of TDO-mediated tryptophan catabolism in glioblastoma cells by a steroid-responsive FKBP52-dependent pathway. 2015 Glia pmid:25132599
Abudou M et al. Immunosuppressants for the prophylaxis of corneal graft rejection after penetrating keratoplasty. 2015 Cochrane Database Syst Rev pmid:26313245
Li Z et al. Tacrolimus Induces Insulin Resistance and Increases the Glucose Absorption in the Jejunum: A Potential Mechanism of the Diabetogenic Effects. 2015 PLoS ONE pmid:26599323
Madariaga ML et al. Kidney-induced cardiac allograft tolerance in miniature swine is dependent on MHC-matching of donor cardiac and renal parenchyma. 2015 Am. J. Transplant. pmid:25824550
Chhatrala R et al. Evolution of serum atherogenic risk in liver transplant recipients: Role of lipoproteins and metabolic and inflammatory markers. 2015 Liver Transpl. pmid:25762084
Soylu H et al. Survival of renal transplant patients: data from a tertiary care center in Turkey. 2015 Transplant. Proc. pmid:25769571
Helmschrott M et al. Advantageous effects of immunosuppression with tacrolimus in comparison with cyclosporine A regarding renal function in patients after heart transplantation. 2015 Drug Des Devel Ther pmid:25759566
Mlih M et al. Na(+)/H (+) exchanger isoform 1 induced osteopontin expression in cardiomyocytes involves NFAT3/Gata4. 2015 Mol. Cell. Biochem. pmid:25758355
Ohe M and Bohgaki T A Case of Adult-Onset Still's Disease Treated with Monitoring of Serum Tacrolimus Levels. 2015 Bull Hosp Jt Dis (2013) pmid:26535602
Xiao A et al. H2S, a novel gasotransmitter, involves in gastric accommodation. 2015 Sci Rep pmid:26531221
Abdel-Azim H et al. Unrelated donor hematopoietic stem cell transplantation for the treatment of non-malignant genetic diseases: An alemtuzumab based regimen is associated with cure of clinical disease; earlier clearance of alemtuzumab may be associated with graft rejection. 2015 Am. J. Hematol. pmid:26242764
Liu X et al. Associations of HSD11B1 polymorphisms with tacrolimus concentrations in Chinese renal transplant recipients with prednisone combined therapy. 2015 Drug Metab. Dispos. pmid:25587129
Ceulemans LJ et al. Nonsteroidal anti-inflammatory drug-induced intestinal graft loss 12 years after transplantation. 2015 Transplantation pmid:25695790
Roche NA et al. Long-Term Multifunctional Outcome and Risks of Face Vascularized Composite Allotransplantation. 2015 J Craniofac Surg pmid:26468783
Blažič M et al. Roles of the crotonyl-CoA carboxylase/reductase homologues in acetate assimilation and biosynthesis of immunosuppressant FK506 in Streptomyces tsukubaensis. 2015 Microb. Cell Fact. pmid:26466669
Stevens RB et al. A Randomized 2x2 Factorial Clinical Trial of Renal Transplantation: Steroid-Free Maintenance Immunosuppression with Calcineurin Inhibitor Withdrawal after Six Months Associates with Improved Renal Function and Reduced Chronic Histopathology. 2015 PLoS ONE pmid:26465152
Wang JY and Fan H P70S6 kinase phosphorylation: a new site to assess pharmacodynamy of sirolimus. 2015 Chin. Med. J. pmid:25698201
Van Driest SL and Webber SA Pharmacogenomics: personalizing pediatric heart transplantation. 2015 Circulation pmid:25645611
Detroyer D et al. Resolution of diffuse skin and systemic Kaposi's sarcoma in a renal transplant recipient after introduction of everolimus: a case report. 2015 Transpl Infect Dis pmid:25645490
Chow SP et al. Long-Term Outcomes of High-Risk Keratoplasty in Patients Receiving Systemic Immunosuppression. 2015 Cornea pmid:26382894
Lin NC et al. Minimization or withdrawal of immunosuppressants in pediatric liver transplant recipients. 2015 J. Pediatr. Surg. pmid:26377868
Garcia MF et al. Behavioral measures to reduce non-adherence in renal transplant recipients: a prospective randomized controlled trial. 2015 Int Urol Nephrol pmid:26377496
Ogul H et al. Severe toxic leukoencephalopathy associated with tacrolimus after living donor liver transplantation. 2015 Acta Neurol Belg pmid:24854146
Tsujiwaki M et al. Warty intralymphatic histiocytosis successfully treated with topical tacrolimus. 2015 J Eur Acad Dermatol Venereol pmid:24851952
Fukushima D et al. Epstein-Barr virus--associated posttransplantation lymphoproliferative disorder with tacrolimus metabolism deterioration in infants after living-donor liver transplantation. 2015 Transplantation pmid:24846306
Elbadri A et al. Factors affecting eGFR 5-year post-deceased donor renal transplant: analysis and predictive model. 2015 Ren Fail pmid:25585951
Tohme FA et al. Conversion to a sirolimus-based regimen is associated with lower incidence of BK viremia in low-risk kidney transplant recipients. 2015 Transpl Infect Dis pmid:25582442
Krystel-Whittemore M et al. Polyomavirus nephropathy of the native kidney in a patient with rheumatoid arthritis and pulmonary fibrosis. 2015 BMJ Case Rep pmid:26318171
Saint-Marcoux F et al. How to handle missed or delayed doses of tacrolimus in renal transplant recipients? A pharmacokinetic investigation. 2015 Pharmacol. Res. pmid:26316426
Karam S and Wali RK Current State of Immunosuppression: Past, Present, and Future. 2015 Crit. Rev. Eukaryot. Gene Expr. pmid:26080606
Ãœnal CM and Steinert M FKBPs in bacterial infections. 2015 Biochim. Biophys. Acta pmid:25529296
Higa M et al. Spatial control of calcineurin in response to heat shock in fission yeast. 2015 Genes Cells pmid:25529221
Lim SW et al. Inhibition of dipeptidyl peptidase IV protects tacrolimus-induced kidney injury. 2015 Lab. Invest. pmid:26237274
Vaeth M et al. Selective NFAT targeting in T cells ameliorates GvHD while maintaining antitumor activity. 2015 Proc. Natl. Acad. Sci. U.S.A. pmid:25583478
Wu B et al. Triple immunosuppressive therapy in steroid-resistant nephrotic syndrome children with tacrolimus resistance or tacrolimus sensitivity but frequently relapsing. 2015 Nephrology (Carlton) pmid:25312783
Namvaran F et al. The Effect of Tacrolimus on Reactive Oxygen Species and Total Antioxidant Status in Pancreatic Beta Cell Line. 2015 Exp Clin Transplant pmid:25431882
Vives R et al. Safety and Activity of UR-1505 in Atopic Dermatitis: A Randomized, Double-blind Phase II Exploratory Trial. 2015 Clin Ther pmid:26163200